Literature DB >> 27582241

Psychiatric Inpatient Discharge Planning Practices and Attendance at Aftercare Appointments.

Thomas E Smith1, Maria Abraham1, Natalia V Bolotnikova1, Sheila A Donahue1, Susan M Essock1, Mark Olfson1, Wenjun S Shao1, Melanie M Wall1, Marleen Radigan1.   

Abstract

OBJECTIVE: This study examined discharge planning practices by hospital providers for 17,053 psychiatric discharges in New York's statewide Medicaid program.
METHODS: Claims data were linked to information reported to New York State by managed behavioral health care organizations (MBHOs) conducting inpatient utilization reviews. MBHOs documented hospital providers' reports of the presence of three discharge planning practices for each discharge: communicating with an outpatient provider prior to discharge, scheduling an aftercare appointment, and forwarding a discharge summary.
RESULTS: Hospital providers reported completing at least one of the three discharge planning practices for 85% of discharges. Individuals who received all three discharge planning practices had a higher likelihood of follow-up and kept their first outpatient follow-up visit at almost twice the speed compared with individuals who received none of the practices (hazard ratio=1.96, p<.001).
CONCLUSIONS: This study provided baseline information concerning routine discharge planning practices and their relationship to timeliness of care transitions.

Entities:  

Keywords:  Care Transitions; Discharge Planning; Engagement; Hospitalization; Inpatient treatment; Mental health systems/hospitals

Mesh:

Year:  2016        PMID: 27582241     DOI: 10.1176/appi.ps.201500552

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  8 in total

1.  Feasibility and Acceptability of the HOME Program for Veterans Recently Discharged from a Psychiatric Hospitalization.

Authors:  Bridget B Matarazzo; Georgia R Gerard; Molly C Jankovsky; David W Oslin; Lisa A Brenner
Journal:  Adm Policy Ment Health       Date:  2021-02-01

2.  Randomized controlled trial of telephone monitoring with psychiatry inpatients with co-occurring substance use and mental health disorders.

Authors:  Christine Timko; Alex H S Harris; Mary Jannausch; Mark Ilgen
Journal:  Drug Alcohol Depend       Date:  2018-10-29       Impact factor: 4.492

3.  Relationship Between Continuity of Care and Discharge Planning After Hospital Psychiatric Admission.

Authors:  Thomas E Smith; Morgan Haselden; Tom Corbeil; Fei Tang; Marleen Radigan; Susan M Essock; Melanie M Wall; Lisa B Dixon; Rui Wang; Eric Frimpong; Steven Lamberti; Matthew Schneider; Mark Olfson
Journal:  Psychiatr Serv       Date:  2019-10-08       Impact factor: 3.084

4.  Do Brief Preventive Interventions for Patients at Suicide Risk Work?

Authors:  Nadine M Melhem; David Brent
Journal:  JAMA Psychiatry       Date:  2020-10-01       Impact factor: 21.596

5.  Measures of Care Coordination at Inpatient Psychiatric Facilities and the Medicare 30-Day All-Cause Readmission Rate.

Authors:  Ivy Benjenk; Morgan Shields; Jie Chen
Journal:  Psychiatr Serv       Date:  2020-08-25       Impact factor: 3.084

6.  Evaluating psychiatric readmissions in the emergency department of a large public hospital.

Authors:  David W Morris; Subroto Ghose; Ella Williams; Kevin Brown; Fuad Khan
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-01       Impact factor: 2.570

Review 7.  [Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].

Authors:  A Chevance; D Gourion; N Hoertel; P-M Llorca; P Thomas; R Bocher; M-R Moro; V Laprévote; A Benyamina; P Fossati; M Masson; E Leaune; M Leboyer; R Gaillard
Journal:  Encephale       Date:  2020-04-02       Impact factor: 1.291

Review 8.  Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review.

Authors:  A Chevance; D Gourion; N Hoertel; P-M Llorca; P Thomas; R Bocher; M-R Moro; V Laprévote; A Benyamina; P Fossati; M Masson; E Leaune; M Leboyer; R Gaillard
Journal:  Encephale       Date:  2020-04-22       Impact factor: 1.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.